GlassScriptPhysician profile
Alice M Mcknight
NPI 1356351316
$860.03
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $195 · 2021: $176.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $248.40 | 2019-2021 | |
| Therapeuticsmd, INC. | $124.61 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $92.62 | 2019 | |
| Avion Pharmaceuticals | $67.02 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.10 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $48.34 | 2019-2021 | |
| Teleflex LLC | $40.06 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $34.11 | 2019-2020 | |
| Lupin INC. | $30.25 | 2019-2020 | |
| Coopersurgical, INC. | $26.51 | 2020-2021 | |
| Duchesnay USA Incorporated | $24.09 | 2019 | |
| Organon LLC | $18.41 | 2021 | |
| Novum Pharma, LLC | $16.04 | 2019 | |
| Mission Pharmacal Company | $14.84 | 2019 | |
| Allergan, INC. | $11.63 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Mcknight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.